Inventive AI has just secured $6.5 million in funding to further propel its innovative approach to revolutionize B2B sales. The company is on a mission to equip sales teams with cutting-edge intelligence to boost their success in clinching deals. Their product, an AI copilot, aids sales teams in navigating the intricate world of RFPs and sales questionnaires with ease and precision. With the ability to analyze and extract crucial information from documents swiftly, generate AI-driven responses, and offer strategic insights on compliance and differentiation, sales teams can enhance their productivity by over 70%. The team behind Inventive AI comprises industry experts with backgrounds in Fortune 500 companies, Google, and Stanford, with strong backing from renowned investors including YCombinator. This latest funding injection will empower Inventive AI to further innovate and empower B2B sales teams to soar to new heights of success in their competitive landscape.
"Inventive AI Secures $6.5M in Seed Funding to Revolutionize B2B Sales with AI Copilot Technology"
Recently funded 路 $6.5M SeedTechnology/Software
Get the full Inventive AI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Aisot Technologies Switzerland | Seed | $2.5M | today |
| 2 |  DIMENSION United States | Seed | $1.6M | today |
